Seres Therapeutics To Present At Canaccord Genuity 35th Annual Growth Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics platform company, today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth Conference held at the InterContinental Hotel in Boston, Mass. The presentation is scheduled for Thursday, August 13, 2015 at 3:00 p.m. (EDT).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC